Antisense Peptide Nucleic Acid–Diaminobutanoic Acid Dendron Conjugates with SbmA-Independent Antimicrobial Activity against Gram-Negative Bacteria

Mirko Iubatti,Isabel Maicas Gabas,Lina M. Cavaco,Elnaz Harifi Mood,Ernest Lim,Federica Bonanno,Niloofar Yavari,Camilla Brolin,Peter E. Nielsen
DOI: https://doi.org/10.1021/acsinfecdis.2c00089
IF: 5.578
2022-04-18
ACS Infectious Diseases
Abstract:Precision antisense antibacterial agents may be developed into novel antibiotics in the fight against multidrug-resistant Gram-negative bacteria. In this study, a series of diaminobutanoic acid (DAB) dendrons are presented as novel carriers for the delivery of antisense antibacterial peptide nucleic acids (PNAs). The dendron-PNA conjugates targeting the essential <i>acpP</i> gene exhibit specific antisense antimicrobial bactericidal activity against <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> at one-digit micromolar concentrations, while showing low toxicity to human cells. One compound selected from a structure-activity relationship series showed high stability in mouse and human serum (<i>t</i><sub>1/2</sub> ≫ 24 h) as well as in vivo activity against a multidrug-resistant, extended spectrum beta-lactamase-producing <i>E. coli</i> in a murine peritonitis model. The compound was also well tolerated in mice upon <i>i.v.</i> administration up to a dose of 20 mg/kg, and in vivo fluorescence imaging indicated clearance via renal excretion with slight accumulation in the kidneys and liver. Thus, DAB-based dendrons constitute a promising new chemistry platform for development of effective delivery agents for antibacterial drugs with possible in vivo use.
chemistry, medicinal,infectious diseases
What problem does this paper attempt to address?